Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
16.96
+2.33 (15.93%)
At close: Nov 4, 2024, 4:00 PM
16.90
-0.06 (-0.35%)
After-hours: Nov 4, 2024, 5:53 PM EST
Monopar Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 87 | 5 | 31 | 40 | 70 | 173 | |
Market Cap Growth | 12.92% | -83.48% | -24.23% | -42.33% | -59.48% | - | |
Enterprise Value | 68 | -3 | 16 | 18 | 52 | 169 | |
Last Close Price | 14.63 | 1.70 | 11.85 | 16.05 | 30.60 | 83.00 | |
PE Ratio | - | -0.56 | -2.87 | -4.40 | -10.64 | -36.62 | |
PB Ratio | 8.46 | 0.91 | 3.03 | 2.13 | 4.47 | 13.70 | |
P/FCF Ratio | -1.87 | -0.64 | -4.24 | -5.52 | -15.03 | -57.32 | |
P/OCF Ratio | -1.87 | -0.64 | -4.24 | -5.52 | -15.03 | -57.32 | |
EV/EBIT Ratio | -0.53 | 0.39 | -1.55 | -1.98 | -8.02 | -38.97 | |
EV/FCF Ratio | -0.58 | 0.44 | -2.26 | -2.47 | -11.20 | -55.84 | |
Debt / Equity Ratio | - | - | 0.00 | - | - | - | |
Debt / FCF Ratio | - | - | 0.00 | - | - | - | |
Quick Ratio | 6.53 | 4.13 | 4.19 | 12.85 | 14.22 | 18.25 | |
Current Ratio | 6.59 | 4.17 | 4.21 | 12.98 | 14.28 | 18.27 | |
Return on Equity (ROE) | -102.31% | -107.19% | -72.44% | -52.57% | -44.52% | -43.23% | |
Return on Assets (ROA) | -53.44% | -53.66% | -39.03% | -30.51% | -26.92% | -26.15% | |
Return on Capital (ROIC) | -67.23% | -70.38% | -45.36% | -32.94% | -28.73% | -27.65% | |
Earnings Yield | -9.47% | -166.13% | -34.34% | -22.52% | -9.00% | -2.44% | |
FCF Yield | -9.06% | -155.38% | -23.61% | -18.11% | -6.65% | -1.74% | |
Buyback Yield / Dilution | -19.36% | -8.69% | -1.97% | -13.82% | -17.56% | -0.32% | |
Total Shareholder Return | -19.36% | -8.69% | -1.97% | -13.82% | -17.56% | -0.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.